Table 2.
Clinical measurement characteristics compared before and after treatment.
| Pretreatment | Posttreatment | p-value | |
|---|---|---|---|
| Responders (n = 34) | |||
| Number of steps | 3480 (2393) | 4246 (2888) | <0.0001 |
| RAND-36 physical activity scale (%) | 34 (18) | 41 (18) | <0.0001 |
| CIS20r fatigue scale | 52 (5) | 50 (6) | <0.01 |
| CIS20r concentration scale | 29 (4) | 29 (4) | ns |
| Vitamin B12 levels (pmol/l) | 379 (289;442) | 1445 (972;1476) | <0.0001 |
| Non-Responders (n = 17) | |||
| Number of steps | 5773 (2137) | 6024 (2304) | ns |
| RAND-36 physical activity scale (%) | 51 (21) | 53 (20) | ns |
| CIS20r fatigue scale | 49 (7) | 49 (7) | ns |
| CIS20r concentration scale | 26 (9) | 26 (9) | ns |
| Vitamin B12 levels (pmol/l) | 265 (228;373) | 395 (354;473) | <0.0001 |
N, number; B12 levels presented as median and IQR; ns, not significant.